HRT Financial’s Adient ADNT Stock Holding History

HRT Financial’s Portfolio ADNT Stock Details ADNT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	–	Sell	-27,374	Closed	-$553K	–	4079
2026 Q1	$553K	Sell	27,374 -70,061	-72%	-$1.56M	﹤0.01%	2444
2025 Q4	$1.87M	Buy	97,435 +70,101	+256%	+$1.47M	0.01%	1349
2025 Q3	$658K	Sell	27,334 -55,299	-67%	-$1.29M	﹤0.01%	1738
2025 Q2	$1.61M	Sell	82,633 -181,483	-69%	-$2.68M	0.01%	1025
2025 Q1	$3.4M	Buy	+264,116	New	+$4.25M	0.02%	589
2024 Q2	–	Sell	-13,000	Closed	-$427K	–	2139
2024 Q1	$427K	Buy	+13,000	New	+$443K	﹤0.01%	1342
2023 Q3	–	Sell	-49,969	Closed	-$1.91M	–	2326
2023 Q2	$1.91M	Buy	49,969 +36,487	+271%	+$1.35M	0.02%	630
2023 Q1	$552K	Buy	+13,482	New	+$563K	0.01%	1294
2021 Q4	–	Sell	-12,394	Closed	-$513K	–	3094
2021 Q3	$513K	Buy	12,394 +6,248	+102%	+$249K	﹤0.01%	1946
2021 Q2	$277K	Buy	+6,146	New	+$287K	﹤0.01%	2198

Other funds holding ADNT

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Pzena Investment Management New York $34.1B AUM 23.81% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $34.3B AUM 22.63% 1-Year Est. Return

Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

HHAM

HITE Hedge Asset Management Braintree, Massachusetts $1.83B AUM 34.36% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

HRT Financial's ADNT Position: Q2 2026 in Review

HRT Financial sold out of Adient (ADNT) in Q2 2026, closing a stake of 27,374 shares — an estimated $553K sold.

HRT Financial first reported a position in ADNT in Q2 2021 and held it in 10 quarters. The position peaked at $3.4M in Q1 2025. 313 funds tracked by Wall St. Rank hold ADNT as of Q2 2026.

HRT Financial reported no remaining Adient position as of Q2 2026 after selling out during the quarter.
HRT Financial sold 27,374 Adient shares in Q2 2026, an estimated $553K.
HRT Financial first reported a position in Adient in Q2 2021 and held it in 10 quarters.
HRT Financial's Adient position peaked at $3.4M in Q1 2025.
313 funds tracked by Wall St. Rank held Adient as of Q2 2026.

Based on HRT Financial's 13F filing for Q2 2026, filed 14 Aug 2026.